Kukje Pharma Co., Ltd. (KRX:002720)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,820.00
-80.00 (-1.63%)
At close: Jun 5, 2025, 3:30 PM KST

Kukje Pharma Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
160,433156,463135,373126,583119,746130,395
Upgrade
Other Revenue
-0-0-0-0-0-
Upgrade
Revenue
160,433156,463135,373126,583119,746130,395
Upgrade
Revenue Growth (YoY)
14.19%15.58%6.94%5.71%-8.17%17.34%
Upgrade
Cost of Revenue
75,63473,96868,14863,32965,27565,590
Upgrade
Gross Profit
84,80082,49567,22563,25454,47064,805
Upgrade
Selling, General & Admin
76,11372,89566,69956,11953,53849,234
Upgrade
Research & Development
2,0951,8112,6461,9672,7723,037
Upgrade
Operating Expenses
79,19175,79369,21457,98256,14658,763
Upgrade
Operating Income
5,6086,702-1,9895,273-1,6766,041
Upgrade
Interest Expense
-1,094-1,206-1,440-1,000-696.43-650.13
Upgrade
Interest & Investment Income
404.5428.67394.02230.88114.3139.41
Upgrade
Earnings From Equity Investments
---23.21-72.91-13.43
Upgrade
Currency Exchange Gain (Loss)
226.25303.91163.51450.12589.96-688.75
Upgrade
Other Non Operating Income (Expenses)
371.72492.72-2,254270.73627.72340.29
Upgrade
EBT Excluding Unusual Items
5,5166,721-5,1265,247-1,1135,169
Upgrade
Gain (Loss) on Sale of Investments
1.10.5922.11--26.38
Upgrade
Gain (Loss) on Sale of Assets
90.9114.27290.3913.9331.51366.75
Upgrade
Asset Writedown
-224.84-226.64-1,867-515.82-28.531.68
Upgrade
Pretax Income
5,3846,609-6,6814,745-1,1105,594
Upgrade
Income Tax Expense
1,0741,4031,7341,202445.533,399
Upgrade
Earnings From Continuing Operations
4,3105,206-8,4153,543-1,5562,195
Upgrade
Minority Interest in Earnings
-0-0.9-0.314.56-3.348.43
Upgrade
Net Income
4,3105,205-8,4153,557-1,5592,203
Upgrade
Net Income to Common
4,3105,205-8,4153,557-1,5592,203
Upgrade
Shares Outstanding (Basic)
202020202020
Upgrade
Shares Outstanding (Diluted)
202020202020
Upgrade
Shares Change (YoY)
0.28%0.53%-0.03%-0.03%-0.03%-0.00%
Upgrade
EPS (Basic)
211.65255.64-415.49175.58-76.93108.67
Upgrade
EPS (Diluted)
211.65255.64-415.49175.58-77.14108.67
Upgrade
Free Cash Flow
182.031,0292,5295,2457,705-6,500
Upgrade
Free Cash Flow Per Share
8.9450.53124.88258.88380.18-320.63
Upgrade
Gross Margin
52.86%52.73%49.66%49.97%45.49%49.70%
Upgrade
Operating Margin
3.50%4.28%-1.47%4.17%-1.40%4.63%
Upgrade
Profit Margin
2.69%3.33%-6.22%2.81%-1.30%1.69%
Upgrade
Free Cash Flow Margin
0.11%0.66%1.87%4.14%6.43%-4.98%
Upgrade
EBITDA
8,7869,9042,2159,7602,7439,667
Upgrade
EBITDA Margin
5.48%6.33%1.64%7.71%2.29%7.41%
Upgrade
D&A For EBITDA
3,1783,2034,2044,4884,4193,626
Upgrade
EBIT
5,6086,702-1,9895,273-1,6766,041
Upgrade
EBIT Margin
3.50%4.28%-1.47%4.17%-1.40%4.63%
Upgrade
Effective Tax Rate
19.94%21.23%-25.34%-60.77%
Upgrade
Advertising Expenses
-3,6926,0157,5047,2506,300
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.